参考文献/References:
[1] Li J,?Li X, Wang Q,et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-retrospective acute myocardial infarction study):a retrospective analysis of hospital data[J]. Lancet,2015,385(9966):441-451.
[2] Svilaas T, van der Horst IC, Zijlstra F. Thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction study(TAPAS)--study design[J]. Am Heart J,2006,151(3):597.e1-597.e7.
[3] Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study(TAPAS):a 1-year follow-up study[J]. Lancet,2008,371(9628):1915-1920.
[4] Yunoki K,Naruko T,Sugioka K,et al. Thrombus aspiration therapy and coronary thrombus components in patients with acute ST-elevation myocardial infarction[J]. J Atheroscler Thromb,2013,20(6):524-537.
[5] Jolly SS,Cairns JA,Yusuf S,et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction:1-year follow-up of the prospective randomised TOTAL trial[J]. Lancet,2016,387(10014):127-135.
[6] Mauri L,Cox D,Hermiller J,et al. The PROXIMAL trial:proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System:a randomized,prospective,multicenter clinical trial[J]. J Am Coll Cardiol,2007,50(15):1442-1449.
[7] Yunoki K,Naruko T,Inoue T,et al. Relationship of thrombus characteristics to the incidence of angiographically visible distal embolization in patients with ST-segment elevation myocardial infarction treated with thrombus aspiration[J]. JACC Cardiovasc Interv,2013,6(4):377-385.
[8] Gatto L,di Landro A,Romagnoli E,et al. A comparison of intracoronary treatment strategies for thrombus burden removal during primary percutaneous coronary intervention:a COCTAIL Ⅱsubstudy[J]. Coron Artery Dis,2018,29(3):186-193.
[9] Kandzari DE,Hasselblad V,Tcheng JE,et al. Improved clinical outcomes with abciximab therapy in acute myocardial infarction:a systematic overview of randomized clinical trials[J]. Am Heart J,
2004,147(3):457-462.
[10] Stone GW,Maehara A,Witzenbichler B,et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction:the INFUSE-AMI randomized trial[J]. JAMA,2012,307(17):1817-1826.
[11] Basuoni A,El-Naggar W,Mahdy M,et al. Effect of intracoronary tirofiban following aspiration thrombectomy on infarct size,in patients with large anterior ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Coron Artery Dis,2020,31(3): 255-259.
[12] Geng T,Zhang JG,Song ZY,et al. Aspiration thrombectomy and intracoronary tirofiban in ST-segment elevation myocardial infarction:combination treatment for patients undergoing primary percutaneous coronary intervention[J]. Herz,2016,41(8):732-740.
[13] Zhang Z, Li W,Wu W,et al. Myocardial reperfusion with tirofiban injection via aspiration catheter:efficacy and safety in STEMI patients with large thrombus burden[J]. Herz,2018,45(3):280-287.
[14] Schneider DJ. Anti-platelet therapy:glycoprotein IIb-IIIa antagonists[J]. Br J Clin Pharmacol,2011,72(4):672-682.
[15] 郭金成,韩雅玲,季福绥,等. 冠状动脉血栓抽吸临床应用专家共识[J]. 中华医学杂志,2017,97(21):1624-1632.
[16] Firman D,Alkatiri AA,Taslim I,et al. Effect of thrombus aspiration on microcirculatory resistance and ventricular function in patients with high thrombus burden[J]. BMC Cardiovasc Disord,2020,20(1):153.
[17] Jolly SS,Cairns JA,Lavi S,et al. Thrombus aspiration in patients with high thrombus burden in the TOTAL trial[J]. J Am Coll Cardiol,2018,72(14):1589-1596.
[18] Gibson CM,de Lemos JA,Murphy SA,et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction:a TIMI 14 substudy[J]. Circulation,2001,103(21):2550-2554.
[19] Sianos G,Papafaklis MI,Daemen J,et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction:the importance of thrombus burden[J]. J Am Coll Cardiol,2007,50(7):573-583.
[20] Tarantini G,Cacciavillani L,Corbetti F,et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty:a study performed with contrast-enhanced magnetic resonance[J]. J Am Coll Cardiol,2005,46(7):1229-1235.
[21] Hugelshofer S,Roffi M,Witassek F,et al. Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary intervention[J]. Am Heart J,2018,204:34-42.
[22] Sim DS,Jeong MH,Ahn Y,et al. Manual thrombus aspiration during primary percutaneous coronary intervention:impact of total ischemic time[J]. J Cardiol,2017,69(2):428-435.
[23] Freund A,Schock S,Stiermaier T,et al. Thrombus aspiration in patients with ST-elevation myocardial infarction presenting late after symptom onset:long-term clinical outcome of a randomized trial[J]. Clin Res Cardiol,2019,108(11):1208-1214.
[24] de Luca G,van’t Hof AW,de Boer MJ,et al. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty[J]. Eur Heart J,2004,25(12):1009-1013.
[25] Rezq A,Saad M. Thrombus aspiration in late presenters with ST-elevation myocardial infarction:a single-center randomized trial [J]. J Interv Cardiol,2018,31(5):632-639.
[26] Jolly SS,Cairns JA,Yusuf S,et al. Randomized trial of primary PCI with or without routine manual thrombectomy[J]. N Engl J Med,2015,372(15):1389-1398.
[27] Qin X,Luo J,Qin L,et al. Long-term impact of thrombus aspiration in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Am J Cardiol,2020,125(10):1471-1478.
[28] Brown ED, Blankenship JC. A mechanism for stroke complicating thrombus aspiration[J]. Catheter Cardiovasc Interv,2017,89(1):93-96.